These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34596223)

  • 1. Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort.
    Mozaffari E; Chandak A; Zhang Z; Liang S; Thrun M; Gottlieb RL; Kuritzkes DR; Sax PE; Wohl DA; Casciano R; Hodgkins P; Haubrich R
    Clin Infect Dis; 2022 Aug; 75(1):e450-e458. PubMed ID: 34596223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
    Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Read SH; Lee E; Der-Torossian C; Gupta R; Berry M; Hollemeersch S; Kalil AC
    Open Forum Infect Dis; 2023 Oct; 10(10):ofad482. PubMed ID: 37869410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States.
    Mozaffari E; Chandak A; Zhang Z; Liang S; Gayle J; Thrun M; Gottlieb RL; Kuritzkes DR; Sax PE; Wohl DA; Casciano R; Hodgkins P; Haubrich R
    Open Forum Infect Dis; 2022 Jan; 9(1):ofab498. PubMed ID: 34984212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients.
    Mandadi S; Pulluru H; Annie F
    PLoS One; 2022; 17(2):e0264301. PubMed ID: 35196344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
    Paules CI; Gallagher SK; Rapaka RR; Davey RT; Doernberg SB; Grossberg R; Hynes NA; Ponce PO; Short WR; Voell J; Wang J; Yang OO; Wolfe CR; Lye DC; Dodd LE; Benson CA
    Clin Infect Dis; 2022 Apr; 74(7):1260-1264. PubMed ID: 34379740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir and Mortality in Patients With Coronavirus Disease 2019.
    Diaz GA; Christensen AB; Pusch T; Goulet D; Chang SC; Grunkemeier GL; McKelvey PA; Robicsek A; French T; Parsons GT; Doherty G; Laurenson C; Roper R; Hadlock J; Cover CJ; Footer B; Robinson P; Micikas M; Marfori JE; Cronenweth C; Mukkamala Y; Mackiewicz J; Rai E; Matson MD; Davila J; Rueda J; Tipton R; Algren H; Ward BC; Malkoski S; Gluckman T; Tallman GB; Arguinchona H; Hammond TC; Standaert S; Christensen J; Echaiz JF; Choi R; McClung D; Pacifico A; Fee M; Sarafian F; Berrington WR; Goldman JD
    Clin Infect Dis; 2022 May; 74(10):1812-1820. PubMed ID: 34409431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.
    Tsuzuki S; Hayakawa K; Uemura Y; Shinozaki T; Matsunaga N; Terada M; Suzuki S; Asai Y; Kitajima K; Saito S; Yamada G; Shibata T; Kondo M; Izumi K; Hojo M; Mizoue T; Yokota K; Nakamura-Uchiyama F; Saito F; Sugiura W; Ohmagari N
    Int J Infect Dis; 2022 May; 118():119-125. PubMed ID: 35192953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.
    Arber N; Shah PL; Assoumou L; Rokx C; De Castro N; Bakhai A; Soriano Viladomiu A; Mateu L; Lumbreras C; Estrada V; Curran A; Sellier PO; Duffy A; Fletcher C; Mozaffari E; Haubrich R; Hodgkins P; Pozniak A; Raffi F
    Infect Dis Now; 2023 Oct; 53(7):104760. PubMed ID: 37454762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment.
    Polivka L; Gajdacsi J; Fazekas L; Sebok S; Barczi E; Hidvegi E; Sutto Z; Dinya E; Maurovich-Horvat P; Szabo AJ; Merkely B; Müller V
    J Glob Health; 2022 Aug; 12():05031. PubMed ID: 36040909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.
    Veronese N; Di Gennaro F; Frallonardo L; Ciriminna S; Papagni R; Carruba L; Agnello D; De Iaco G; De Gennaro N; Di Franco G; Naro L; Brindicci G; Rizzo A; Bavaro DF; Garlisi MC; Santoro CR; Signorile F; Balena F; Mansueto P; Milano E; Giannitrapani L; Fiordelisi D; Mariani MF; Procopio A; Lattanzio R; Licata A; Vernuccio L; Amodeo S; Guido G; Segala FV; Barbagallo M; Saracino A
    Sci Rep; 2024 Apr; 14(1):9303. PubMed ID: 38654033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Efficacy of Injection Remdesivir in Patients of COVID-19.
    Chaudhary BR; Dudhrejia PJ; Gambhir RM; Rathod MM
    J Assoc Physicians India; 2023 Apr; 71(4):11-12. PubMed ID: 37355792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19.
    Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Berry M; Oppelt T; Okulicz JF; Amin AN; Welte T; Sax PE; Kalil AC
    Clin Infect Dis; 2024 Sep; ():. PubMed ID: 39302162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation.
    Padilla S; Polotskaya K; Fernández M; Gonzalo-Jiménez N; de la Rica A; García JA; García-Abellán J; Mascarell P; Gutiérrez F; Masiá M
    J Antimicrob Chemother; 2022 Jul; 77(8):2257-2264. PubMed ID: 35534369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales.
    Rafia R; Martyn-St James M; Harnan S; Metry A; Hamilton J; Wailoo A
    Value Health; 2022 May; 25(5):761-769. PubMed ID: 35197225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5.
    Molina KC; Webb BJ; Kennerley V; Beaty LE; Bennett TD; Carlson NE; Mayer DA; Peers JL; Russell S; Wynia MK; Aggarwal NR; Ginde AA
    BMC Infect Dis; 2024 Aug; 24(1):802. PubMed ID: 39118052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.
    Mozaffari E; Chandak A; Chima-Melton C; Kalil AC; Jiang H; Lee E; Der-Torossian C; Thrun M; Berry M; Haubrich R; Gottlieb RL
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae202. PubMed ID: 38894848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients.
    Coelho L; Falcão F; Póvoa P; Viegas E; Martins AP; Carmo E; Fonseca C; Campos L; Mansinho K; Carmo I; Soares J; Solano M; Mendes D; Miranda AC; Carvalho A; Mirco A; Farinha H; Aldir I; Correia J
    Sci Rep; 2023 Mar; 13(1):4482. PubMed ID: 36934143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.